Daniel T Scavilla
Insider
First SEC filing: May 15, 2015 · Latest: May 26, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | XRAY | F | 4,095 | $10.21 | $41,810 | 157,754 Direct | -2.53% | Disposed | -16.2% (price as of 2026-10-05) |
| March 11, 2026 | XRAY | A | 3,555 | $11.43 | $40,634 | 3,555 Direct | · | Acquired | -25.1% (price as of 2026-10-05) |
| March 4, 2026 | XRAY | A | 2,066,600 | · | · | 2,066,600 Direct | · | Acquired | (price as of 2026-10-05) |
| March 4, 2026 | XRAY | A | 145,089 | · | · | 161,839 Direct | +866.20% | Acquired | (price as of 2026-10-05) |
| Feb. 24, 2026 | XRAY | F | 1,194 | $13.14 | $15,689 | 16,750 Direct | -6.65% | Disposed | -34.9% (price as of 2026-10-05) |
| Jan. 9, 2026 | XRAY | A | 246 | · | · | 17,945 Direct | +1.39% | Acquired | (price as of 2026-10-05) |
| Oct. 10, 2025 | XRAY | A | 224 | · | · | 17,699 Direct | +1.28% | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2025 | XRAY | A | 1,102,600 | · | · | 1,102,600 Direct | · | Acquired | (price as of 2026-10-05) |
| July 11, 2025 | XRAY | A | 210 | · | · | 17,475 Direct | +1.22% | Acquired | (price as of 2026-10-05) |
| May 22, 2025 | XRAY | A | 13,880 | · | · | 17,265 Direct | +410.04% | Acquired | (price as of 2026-10-05) |
| Feb. 24, 2025 | XRAY | A | 3,385 | · | · | 3,385 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 23, 2025 | GMED | A | 140,000 | · | · | 140,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 21, 2024 | GMED | M | 80,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Nov. 21, 2024 | GMED | M | 50,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Nov. 21, 2024 | GMED | S 10b5-1 | 130,000 | $85.00 | $11,050,000 | 0 Direct | -100.00% | Disposed | -9.9% (price as of 2026-10-05) |
| Nov. 21, 2024 | GMED | M | 80,000 | $43.58 | $3,486,400 | 130,000 Direct | +160.00% | Acquired | 75.7% (price as of 2026-10-05) |
| Nov. 21, 2024 | GMED | M | 50,000 | $43.77 | $2,188,500 | 50,000 Direct | · | Acquired | 74.9% (price as of 2026-10-05) |
| Nov. 6, 2024 | GMED | M | 30,000 | · | · | 50,000 Direct | +150.00% | Acquired | (price as of 2026-10-05) |
| Nov. 6, 2024 | GMED | M | 30,000 | · | · | 0 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 6, 2024 | GMED | S 10b5-1 | 60,000 | $80.02 | $4,801,200 | 0 Direct | -100.00% | Disposed | -4.3% (price as of 2026-10-05) |
| Nov. 6, 2024 | GMED | M | 30,000 | $43.77 | $1,313,100 | 60,000 Direct | +100.00% | Acquired | 74.9% (price as of 2026-10-05) |
| Nov. 6, 2024 | GMED | M | 30,000 | $26.27 | $788,100 | 30,000 Direct | · | Acquired | 191.5% (price as of 2026-10-05) |
| Jan. 26, 2024 | GMED | A | 140,000 | · | · | 140,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 10, 2023 | GMED | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 26, 2023 | GMED | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 21, 2022 | GMED | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 27, 2022 | GMED | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-05) |
| July 2, 2021 | GMED | M | 50,000 | · | · | 30,000 Direct | -62.50% | Disposed | (price as of 2026-10-05) |
| July 2, 2021 | GMED | M | 50,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| July 2, 2021 | GMED | S 10b5-1 | 400 | $78.97 | $31,588 | 0 Direct | -100.00% | Disposed | -3.0% (price as of 2026-10-05) |
| July 2, 2021 | GMED | S 10b5-1 | 99,600 | $78.41 | $7,809,636 | 400 Direct | -99.60% | Disposed | -2.3% (price as of 2026-10-05) |
| July 2, 2021 | GMED | M | 50,000 | $26.27 | $1,313,500 | 100,000 Direct | +100.00% | Acquired | 191.5% (price as of 2026-10-05) |
| July 2, 2021 | GMED | M | 50,000 | $25.52 | $1,276,000 | 50,000 Direct | · | Acquired | 200.0% (price as of 2026-10-05) |
| Jan. 14, 2021 | GMED | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 21, 2020 | GMED | M | 68,750 | · | · | 50,000 Direct | -57.89% | Disposed | (price as of 2026-10-05) |
| May 21, 2020 | GMED | M | 31,250 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| May 21, 2020 | GMED | S 10b5-1 | 100,000 | $55.09 | $5,509,000 | 0 Direct | -100.00% | Disposed | 39.0% (price as of 2026-10-05) |
| May 21, 2020 | GMED | M | 68,750 | $25.52 | $1,754,500 | 100,000 Direct | +220.00% | Acquired | 200.0% (price as of 2026-10-05) |
| May 21, 2020 | GMED | M | 31,250 | $25.40 | $793,750 | 31,250 Direct | · | Acquired | 201.5% (price as of 2026-10-05) |
| Jan. 22, 2020 | GMED | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 22, 2019 | GMED | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 10, 2018 | GMED | M | 31,250 | · | · | 118,750 Direct | -20.83% | Disposed | (price as of 2026-10-05) |
| April 10, 2018 | GMED | M | 50,540 | · | · | 31,250 Direct | -61.79% | Disposed | (price as of 2026-10-05) |
| April 10, 2018 | GMED | S 10b5-1 | 31,250 | $50.00 | $1,562,500 | 0 Direct | -100.00% | Disposed | 53.1% (price as of 2026-10-05) |
| April 10, 2018 | GMED | M | 31,250 | $25.52 | $797,500 | 31,250 Direct | · | Acquired | 200.0% (price as of 2026-10-05) |
| April 10, 2018 | GMED | S 10b5-1 | 50,540 | $50.00 | $2,527,000 | 0 Direct | -100.00% | Disposed | 53.1% (price as of 2026-10-05) |
| April 10, 2018 | GMED | M | 50,540 | $25.40 | $1,283,716 | 50,540 Direct | · | Acquired | 201.5% (price as of 2026-10-05) |
| April 9, 2018 | GMED | M | 18,210 | · | · | 81,790 Direct | -18.21% | Disposed | (price as of 2026-10-05) |
| April 9, 2018 | GMED | S 10b5-1 | 18,210 | $50.00 | $910,500 | 0 Direct | -100.00% | Disposed | 53.1% (price as of 2026-10-05) |
| April 9, 2018 | GMED | M | 18,210 | $25.40 | $462,534 | 18,210 Direct | · | Acquired | 201.5% (price as of 2026-10-05) |
| Jan. 22, 2018 | GMED | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 30, 2017 | GMED | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 25, 2016 | GMED | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 11, 2026 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock | · | · | 3,555 | Acquired |
| March 4, 2026 | XRAY | Stock Option (Right to Buy) | Common Stock | $15.46 | March 4, 2036 | 2,066,600 | Acquired |
| Aug. 8, 2025 | XRAY | Stock Option (Right to Buy) | Common Stock | $12.96 | Aug. 8, 2035 | 1,102,600 | Acquired |
| Jan. 23, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $92.42 | Jan. 23, 2035 | 140,000 | Acquired |
| Nov. 21, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.58 | Jan. 22, 2029 | 80,000 | Disposed |
| Nov. 21, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 50,000 | Disposed |
| Nov. 6, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 30,000 | Acquired |
| Nov. 6, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 30,000 | Acquired |
| Jan. 26, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.75 | Jan. 26, 2034 | 140,000 | Acquired |
| Oct. 10, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.02 | Sept. 1, 2033 | 10,000 | Acquired |
| Jan. 26, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $75.18 | Jan. 26, 2033 | 100,000 | Acquired |
| April 21, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $79.00 | April 21, 2032 | 60,000 | Acquired |
| Jan. 27, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $63.68 | Jan. 27, 2032 | 40,000 | Acquired |
| July 2, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 50,000 | Disposed |
| July 2, 2021 | GMED | Stock Option (Right to buy Class A Common Stock) | Class A Common Stock | $25.52 | Jan. 25, 2026 | 50,000 | Disposed |
| Jan. 14, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $65.05 | Jan. 14, 2031 | 50,000 | Acquired |
| May 21, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.52 | Jan. 25, 2026 | 68,750 | Disposed |
| May 21, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.40 | April 8, 2025 | 31,250 | Disposed |
| Jan. 22, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 80,000 | Acquired |
| Jan. 22, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.58 | Jan. 22, 2029 | 80,000 | Acquired |
| April 10, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.52 | Jan. 25, 2026 | 31,250 | Disposed |
| April 10, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.40 | April 8, 2025 | 50,540 | Disposed |
| April 9, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.40 | April 8, 2025 | 18,210 | Disposed |
| Jan. 22, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 80,000 | Acquired |
| Jan. 30, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 80,000 | Acquired |
| Jan. 25, 2016 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.52 | Jan. 25, 2026 | 150,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $431,753 | $1,079,315 | $3,484,488 | $3,221,523 | $437,150 | · | $105,910 | $8,760,139 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $284,616 | · | · | · | · | · | $25,678 | $5,316,939 |
| 2024 | $481,077 | · | · | $2,936,886 | $1,404,150 | · | $36,547 | $4,858,660 |
| 2023 | $463,500 | $150,000 | · | $2,896,394 | $1,021,500 | · | $32,980 | $4,564,374 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.